European Neuropsychopharmacology

Papers
(The H4-Index of European Neuropsychopharmacology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders327
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility284
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder104
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism87
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA76
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review68
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders65
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS56
P.0224 Dosing regimen overview of treatment-resistant depression patients treated with esketamine: eskale study interim analysis56
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES55
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD51
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)50
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES48
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE46
83. DAMAGING RARE CODING VARIANTS IDENTIFIED BY EXOME SEQUENCING ARE ASSOCIATED WITH REDUCED COGNITIVE FUNCTION IN SCHIZOPHRENIA46
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS46
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES45
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES44
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION41
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD40
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD40
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY40
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA40
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER38
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT38
P.0016 Concomitant drug abuse in patients on methadone maintenance treatment37
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT37
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS36
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS35
W13. CLINICAL VALUE OF DIAGNOSTIC WHOLE GENOME/EXOME SEQUENCING IN FAMILIAL AUTISM SPECTRUM DISORDER33
TU90. STUDY OF GENETIC POLYMORPHISM AND DNA METHYLATION IN TUMOR NECROSIS FACTOR- ALPHA (TNF-Α) AND TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 (TM6SF2) IN ALCOHOL INDUCED LIVER CIRRHOSIS33
W14. GENETIC CLUSTERING OF CO-OCCURRING SYMPTOMS IN PEOPLE WITH AUTISM: A MULTIVARIATE GENETIC VARIANCE ANALYSIS OF GENETIC RELATIONSHIP MATRICES IN THE SPARK SAMPLE32
ASSESSING THE EFFECTS OF RARE COPY NUMBER VARIANTS ON PSYCHIATRIC SYMPTOMS AND COGNITIVE ABILITY IN ∼1M INDIVIDUALS32
PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS32
Society Calendar32
0.414959192276